SARS-Cov-2 mRNA Vaccine-Induced Immune Responses in Rheumatoid Arthritis
Description
Our objective was to characterize T and B-cell responses to vaccination with SARS-CoV-2 antigens in immunocompromised rheumatoid arthritis (RA) patients. In 22 RA patients, clinical and biological variables were analyzed before and four weeks after
